Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Tuesday 13 February, 2018

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 7928E
GlaxoSmithKline PLC
13 February 2018
 

GlaxoSmithKline plc (the 'Company')

Conditional Share Awards and Shares withheld or sold to meet tax liabilities

This notification sets out the details of the vesting of awards and the sale or withholding of shares to meet tax liabilities over Ordinary Shares made in 2015 under the GlaxoSmithKline Share Value Plan (SVP), which were conditional on continued employment with the GlaxoSmithKline group. The restricted period for the 2015 SVP awards has now ended and the awards made to Persons Discharging Managerial Responsibility (PDMRs) vested on 12 February 2018.

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr L Debruyne

b)

Position/status

President, Global Vaccines

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

 

 

 

 

 

 

 

b)

Nature of the transaction

The vesting and release of Ordinary Shares awarded in 2015 under the Company's 2009 Share Value Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

n/a

6,433

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

 

 

e)

Date of the transaction

2018-02-12

f)

Place of the transaction

 

London Stock Exchange (XLON)

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mrs V A Whyte

b)

Position/status

Company Secretary

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

 

 

 

 

 

 

 

b)

Nature of the transaction

The vesting and release of Ordinary Shares awarded in 2015 under the Company's 2009 Share Value Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

n/a

11,060

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

 

 

e)

Date of the transaction

2018-02-12

f)

Place of the transaction

 

London Stock Exchange (XLON)

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mrs V A Whyte

b)

Position/status

Company Secretary

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

 

 

 

 

 

 

 

b)

Nature of the transaction

The sale of Ordinary Shares to meet tax liabilities further to the vesting and release of the 2015 award under the Company's 2009 Share Value Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£12.9521

5,199

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

 

 

e)

Date of the transaction

2018-02-12

f)

Place of the transaction

 

London Stock Exchange (XLON)

 

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHQXLFFVLFZBBL

a d v e r t i s e m e n t